SEARL has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc

SEARL in a notice informed that it has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc for the “recombinant novel coronavirus vaccine(V-01)’ which also covers manufacturing transition of (V-01) in Pakistan.

spot_img

More like this

Breaking Barriers: KSE-100 Index Hits Historic 100,000 Points –...

Today, the KSE-100 Index of the Pakistan Stock Exchange (PSX) reached the historic milestone of 100,000 points...

Rollover Pressure and Political Chaos Drag KSE-100 Down 3,506...

Today's trading session on the Pakistan Stock Exchange (PSX) saw a notable downturn. The benchmark KSE-100 Index...

KSE 100 Skyrockets to Historic 78k Milestone!

The Pakistan Stock Exchange (PSX) experienced a buying frenzy as the benchmark KSE-100 index surged by over...